In a quite recent phase II clinical trial, a cohort of men with asymptomatic or minimally symptomatic prostate cancer with rising PSA were treated with acai juice product (NCT01521949 [121]) (Table 1). The gene discussed is KLK3; the disease is Familial prostate cancer.